For example, Lee et al. enhanced the delivery and transfection efficiency of siRNA in cancer cells by conjugating the EphA2 ligand, Ephrin-A1, on the surface of LNPs, taking advantage of the overexpression of the EphA2 receptor in most cancer cells [108]. This evidence concerns the gene EFNA1 and cancer.